This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohen, D Articles by Ofek, I Search for Related Content PubMed PubMed Citation Articles by Cohen, D Articles by Ofek, I

Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis.

Israel Defence Force, Tel Hashomer.

ABSTRACT

A means for determining immune status against shigellosis would significantly improve the design and evaluation of interventional and other epidemiologic studies. Previous case-control studies have indicated the potential role of humoral antilipopolysaccharide antibodies. To test this proposition, 190 soldiers serving in a field unit were monitored prospectively for 2.5 months for shigellosis. Blood samples were taken at the beginning of the follow-up period and tested for serological evidence of prior exposure to Shigella sonnei and Shigella flexneri. The risk for acquiring S. sonnei shigellosis was 3.7 times higher for individuals lacking homologous antibodies (P less than 0.02). The risk for acquiring S. flexneri shigellosis was 2.4 times higher for individuals lacking antibodies, although a low attack rate for S. flexneri resulted in numbers too small to achieve statistical significance. While the importance of the serum antilipopolysaccharide antibodies in protection against the disease remains unclear, these findings demonstrate that they are strong markers of acquired immunity. Serological markers should be incorporated in epidemiologic studies of shigellosis and in the design and evaluation of future trials of potential anti-Shigella vaccines.

This article has been cited by other articles:

• Chowers, Y., Kirschner, J., Keller, N., Barshack, I., Bar-Meir, S., Ashkenazi, S., Schneerson, R., Robbins, J., Passwell, J. H. (2007). O-Specific polysaccharide conjugate vaccine-induced IgG antibodies prevent invasion of Shigella into Caco-2 cells and may be curative. Proc. Natl. Acad. Sci. USA 104: 2396-2401 [Abstract] [Full Text]  
• Suzuki, T., Yoshikawa, Y., Ashida, H., Iwai, H., Toyotome, T., Matsui, H., Sasakawa, C. (2006). High Vaccine Efficacy against Shigellosis of Recombinant Noninvasive Shigella Mutant That Expresses Yersinia Invasin. J. Immunol. 177: 4709-4717 [Abstract] [Full Text]  
• Fries, L. F., Montemarano, A. D., Mallett, C. P., Taylor, D. N., Hale, T. L., Lowell, G. H. (2001). Safety and Immunogenicity of a Proteosome-Shigella flexneri 2a Lipopolysaccharide Vaccine Administered Intranasally to Healthy Adults. Infect. Immun. 69: 4545-4553 [Abstract] [Full Text]  
• Passwell, J. H., Harlev, E., Ashkenazi, S., Chu, C., Miron, D., Ramon, R., Farzan, N., Shiloach, J., Bryla, D. A., Majadly, F., Roberson, R., Robbins, J. B., Schneerson, R. (2001). Safety and Immunogenicity of Improved Shigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel. Infect. Immun. 69: 1351-1357 [Abstract] [Full Text]  
• Bernardini, M. L., Arondel, J., Martini, I., Aidara, A., Sansonetti, P. J. (2001). Parameters Underlying Successful Protection with Live Attenuated Mutants in Experimental Shigellosis. Infect. Immun. 69: 1072-1083 [Abstract] [Full Text]  
• Kotloff, K. L., Noriega, F. R., Samandari, T., Sztein, M. B., Losonsky, G. A., Nataro, J. P., Picking, W. D., Barry, E. M., Levine, M. M. (2000). Shigella flexneri 2a Strain CVD 1207, with Specific Deletions in virG, sen, set, and guaBA, Is Highly Attenuated in Humans. Infect. Immun. 68: 1034-1039 [Abstract] [Full Text]  
• Pavliakova, D., Chu, C., Bystricky, S., Tolson, N. W., Shiloach, J., Kaufman, J. B., Bryla, D. A., Robbins, J. B., Schneerson, R. (1999). Treatment with Succinic Anhydride Improves the Immunogenicity of Shigella flexneri Type 2a O-Specific Polysaccharide-Protein Conjugates in Mice. Infect. Immun. 67: 5526-5529 [Abstract] [Full Text]